title: Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells.
abstract: Infections with encapsulated bacteria cause serious clinical problems. Besides being poorly immunogenic, the bacterial capsular polysaccharide (CPS) cloaks antigenic proteins, allowing bacterial evasion of the host immune system. Despite the clinical significance of bacterial CPS and its suggested role in the pathogenesis of the infection, the mechanisms underlying innate and, critically, adaptive immune responses to encapsulated bacteria have not been fully elucidated. As such, we became interested in studying the CPS of two similar, but unique, streptococcal species: Group B  Streptococcus  (GBS) and  Streptococcus suis . Both streptococci are well encapsulated, some capsular types are more virulent than others, and they can cause severe meningitis and septicemia. For both pathogens, the CPS is considered the major virulence factor. Finally, these two streptococci are the sole Gram-positive bacteria possessing sialic acid in their capsules. GBS type III is a leading cause of neonatal invasive infections. Streptococcus suis type 2 is an important swine and emerging zoonotic pathogen in humans. We recently characterized the S. suis type 2 CPS. It shares common structural elements with GBS, but sialic acid is α2,6-linked to galactose rather than α2,3-linked. Differential sialic acid expression by pathogens might result in modulation of immune cell activation and, consequently, may affect the immuno-pathogenesis of these bacterial infections. Here, we review and compare the interactions of these two sialylated encapsulated bacteria with dendritic cells, known as the most potent antigen-presenting cells linking innate and adaptive immunity. We further address differences between dendritic cells and professional phagocytes, such as macrophages and neutrophils, in their interplay with these encapsulated pathogens. Elucidation of the molecular and cellular basis of the impact of CPS composition on bacterial interactions with immune cells is critical for mechanistic understanding of anti-CPS responses. Knowledge generated will help to advance the development of novel, more effective anti-CPS vaccines and improved immunotherapies.
authors.affiliation: Laboratory of Immunology, Department of Pathology and Microbiology, Faculty of Veterinary Medicine, Université de Montréal, 3200 rue Sicotte, St-Hyacinthe, QC J2S 2M2, Canada. mariela.segura@umontreal.ca
authors.forename: Mariela
authors.initials: M
authors.lastname: Segura
mesh_terms: D000818:Animals; D016667:Bacterial Capsules / Q000737:chemistry / Q000276:immunology*; D003713:Dendritic Cells / Q000276:immunology / Q000382:microbiology; D054884:Host-Pathogen Interactions; D006801:Humans; D019158:N-Acetylneuraminic Acid / Q000378:metabolism; D011135:Polysaccharides, Bacterial / Q000737:chemistry / Q000276:immunology*; D013290:Streptococcal Infections / Q000276:immunology / Q000382:microbiology*; D013292:Streptococcus agalactiae / Q000737:chemistry / Q000276:immunology*; D017011:Streptococcus suis / Q000737:chemistry / Q000276:immunology*
chemical_list: D011135:Polysaccharides, Bacterial; D019158:N-Acetylneuraminic Acid